Drug Profile
Research programme: GABA A receptor inverse agonists - Roche
Alternative Names: L-792,782; RO; RO 4882224; RO 4938581Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Roche
- Class Benzodiazepines
- Mechanism of Action GABA A alpha 5 receptor inverse agonists; GABA A receptor inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cognition-disorders in Switzerland (PO)
- 10 Dec 2009 Pharmacodynamics data from a preclinical trial in Cognition disorders presented at the 48th Annual Meeting of the American College of Neuropsychopharmacology (ACNP-2009)
- 04 Sep 2007 Preclinical trials in Cognition disorders in Switzerland (PO)